Impact of the Daily Use of the Tested Emollient on Corticosteroids Consumption in Patients Minimum 3 Years Old With Atopic Dermatitis (SCORAD 20-30) Versus Their Usual Emollient
Sponsor study identifier
observational
119
1 country
1
Study Start
October 14, 2020
Actual (reported)Primary Completion
July 14, 2021
Actual (reported)Study Completion
July 14, 2021
Actual (reported)This study aims at assessing the reduction of consumption of corticosteroids (same mid-potent corticosteroids for all patients) afforded by the use of a specific emollient in comparison to the usual one in subjects suffering from atopic dermatitis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 14, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 14, 2020
Actual (reported)July 14, 2021
Actual (reported)July 14, 2021
Actual (reported)November 21, 2022
Actual (reported)December 9, 2022
Actual (reported)efficacy of treatments
the efficacy of treatments is evaluated by corticosteroids consumption (weight of product and number of applications)
from baseline to Day84
change in SCORing Atopic Dermatitis (SCORAD) measure
from baseline to Day84
change in Patient-Oriented SCORing Atopic Dermatitis (PO-SCORAD) measure
from baseline to Day84
change in LOCAL SCORing Atopic Dermatitis (LOCAL SCORAD) measure
from baseline to Day84
change in cutaneous discomfort
from baseline to Day84
change in global efficacy
from Day28 to Day84
The group applies Lipikar Baume AP+M twice daily for 3 months. Participants have 4 visits (Day0, Day 28, Day56, Day84) with different outcome measures including self-evaluations).
The group applies their usual emollient twice daily for 3 months. Participants have 4 visits (Day0, Day28, Day56, Day84 with different outcome measures including self-evaluations).
application of Lipikar Baume AP+M twice daily for 3 months in parallel with the corticosteroid treatment
application of the usual emollient twice daily for 3 months in parallel with the corticosteroid treatment
Patients meeting the inclusion and exclusion criteria and agreeing to participate in the study
DOST
Svidník, 08901, Slovakia
Caroline Le Floc'h
Cosmetique Active International
119 participants (actual enrollment reported by the registry).
First Submitted
November 21, 2022
First Posted
December 9, 2022
Study Start
October 14, 2020
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
July 14, 2021
Actual (reported)Study Completion
July 14, 2021
Actual (reported)Last Updated
December 9, 2022
Record last verified: 2022-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: